Loading clinical trials...
Loading clinical trials...
Abiomed Impella Pump Return Registry - Observational Study
Analysis of cell and protein deposits on the Impella Heart Pump.
The Impella heart pump supports patients in cardiogenic shock for various reasons and has passed safety and biocompatibility evaluations. The planned investigation aims to further analyze cell and protein adhesion on these pumps and the effects of their prolonged use, especially in scenarios like bridge-to-transplant, recognizing preclinical testing limitations.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Herzzentrum Dresden
Dresden, Saxony, Germany
Herzzentrum Leipzig
Leipzig, Saxony, Germany
Deutsches Herzzentrum der Charité Berlin
Berlin, Germany
Uniklinik Köln
Cologne, Germany
Westdeutsches Herz- und Gefäßzentrum Essen
Essen, Germany
Start Date
September 21, 2025
Primary Completion Date
July 31, 2030
Completion Date
January 31, 2031
Last Updated
October 3, 2025
200
ESTIMATED participants
Christian Cremer, CPM
CONTACT
Lead Sponsor
Abiomed Inc.
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions